Abstract
Objective To evaluate the relationship between use of fertility medication (i.e., selective estrogen receptor [ER] modulator, gonadotropin, or other) or infertility treatment (i.e., IVF or IUI) and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. Design A matched case-control study of 941 pairs of BRCA1 or BRCA2 mutation carriers with and without a diagnosis of ovarian cancer. Setting Genetic clinics. Patient(s) Detailed information regarding treatment of infertility was collected from a routinely administered questionnaire. Intervention(s) None. Main Outcome Measure(s) Conditional logistic regression was used to estimate odds ratios and 95% confidence intervals associated with fertility treatment. Result(s) There was no significant relationship between the use of any fertility medication or IVF treatment (odds ratio, 0.66; 95% confidence interval 0.18-2.33) and the subsequent risk of ovarian cancer. Conclusion(s) Our findings suggest that treatment for infertility does not significantly increase the risk of ovarian cancer among women with a BRCA mutation.
Original language | English |
---|---|
Pages (from-to) | 781-785 |
Number of pages | 5 |
Journal | Fertility and Sterility |
Volume | 105 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1 2016 |
Keywords
- Adult
- Aged
- BRCA1 Protein/genetics
- BRCA2 Protein/genetics
- Case-Control Studies
- Chi-Square Distribution
- DNA Mutational Analysis
- Female
- Fertility Agents, Female/administration & dosage
- Fertility/drug effects
- Fertilization in Vitro
- Genetic Predisposition to Disease
- Humans
- Infertility/diagnosis
- Insemination, Artificial
- Logistic Models
- Middle Aged
- Multivariate Analysis
- Mutation
- Odds Ratio
- Ovarian Neoplasms/genetics
- Pregnancy
- Reproductive Techniques, Assisted/adverse effects
- Risk Assessment
- Risk Factors
- Surveys and Questionnaires
- Treatment Outcome
- Young Adult